Molycorp Approves Phase 2 Expansion of REOs at Mountain Pass

Molycorp, Inc., producer of rare earth oxides (REOs), announced that Phase 2 of its expansion plan has been approved. The plan is expected to double the production capacity of its Mountain Pass facility in California.

Together with this plan, Molycorp has filed with the U.S. Securities and Exchange Commission (SEC) in connection with a proposed mandatory convertible preferred stock offering by the Company as well as an offering of common stock by certain stockholders.

This move is in light of strong industry fundamentals and a strong pricing environment vis-a-vis reduced Chinese supply. The approval is expected to give Molycorp the ability to produce up to approximately 40,000 metric tons of REOs annually through its Mountain Pass facility by the end of 2013. The expansion represents a doubling of the original Phase 1 production capacity equivalent per year. The Phase 1 plan was estimated at a capital cost of approximately US$250 million. Molycorp believes that it will realize substantial savings by committing to this expansion now while construction activities are underway for its Phase 1 initial modernization and expansion plan.

Molycorp will also set its REO products into the market at rates commensurate with customer and demand growth. It expects to use the net proceeds from the proposed mandatory convertible preferred stock offering to fund its Phase 1 and Phase 2 plans.

The proposed secondary offering will help facilitate the liquidity objectives of the selling stockholders. This will be done through an orderly underwritten offering and will provide additional public float with respect to Molycorp’s common stock. The principal selling stockholders are affiliates of Resource Capital Funds, Pegasus Capital Advisors, L.P., and The Traxys Group, which are the three main investors that led the purchase of the Mountain Pass Rare Earth Facility in 2008. These selling stockholders will remain substantial investors in Molycorp immediately after the offering.

“Without the foresight and long-term, strategic commitment of Resource Capital Funds, Pegasus Capital Advisors, and The Traxys Group, Molycorp would not be in the position we are today. Their willingness to take on significant, early stage risk has positioned Molycorp, and all of our stakeholders, to continue to benefit from the very positive fundamentals of the rare earth sector.”

Mark Smith, Molycorp Chief Executive Officer and Board of Directors Member

J.P. Morgan Securities and Morgan Stanley & Co. will act as joint book-running managers for the proposed offerings.

Hot this week

Did David Wineland and Serge Haroche Steal Idea For The Nobel Physics Prize?

Dr. Omerbashich says the Royal Swedish Academy is a Crime Scene and he has the proof that Nobel laureates stole his discovery.

New Approaches to Disaster Relief Challenges

Disaster relief has always been a challenge. NASA, Google,...

3 Legitimate Money Making Methods to Supplement Your Income

In a perfect world, when your landlord raises your...

2016 Predictions by World Renowned Medium and Psychic Lindy Baker

World renowned medium and psychic Lindy Baker is interviewed by The Hollywood Sentinel, discussing psychic power, the spirit world, life after death, areas of concern in 2016, and much more.

Digital Coupon Customers Spending More Than Double At Stores

A new study shows that customers who use digital coupons go shopping more for groceries and other household goods more often and spend more on their shopping trips.

“One Flag Forward” Leads the Way  

From the USS Intrepid, up the Hudson River Greenway to the George Washington Bridge, New Yorkers ran to support the first day of One Flag Forward.

Will Roberts Returns to Carmel to Emcee International Film Festival

Will Roberts returns to Carmel to emcee the 2026 film festival as new film and television projects add to a busy year.

The Anesthesia Question Cosmetic Surgery Patients Forget to Ask

Where your operation happens and who administers the anesthesia are the two variables that never appear as line items on a cosmetic surgery quote.

The San Francisco Tribune Highlights Nine Companies Reshaping Enterprise AI

The most interesting work in artificial intelligence right now...

Occupational Hazard: The First Coral Reefers – Another Band Bites the Dust

The story of Occupational Hazard: The First Coral Reefers, as another band bites the dust, Jimmy Buffett and the Coral Reefers.

The DNA Company Takes Functional Genomics Beyond DNA Reports

The DNA Company connects genetic data, scientific review, education and personalized support under CEO Tracy Wood.

The Neck Ages First, and Surgeons Now Treat It on Its Own

Neck lifts are growing faster than facelifts in the US. The approach at FACES+ in San Diego shows why the neck has become the starting point.

Related Articles

Popular Categories